Search results
UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study
Reuters via Yahoo Finance· 3 months agoSeelos Therapeutics' experimental ALS drug did not meet the main goal of a mid-stage trial, the company said on Tuesday, the latest study setback in a field littered with clinical failures.
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive via Yahoo Finance· 1 year agoKey Takeaways; Cannabis Sector Tilray plummeted 21% on Friday, after announcing a registered offering of $150 million worth of convertible notes. SNDL reported growth in sales over last year ...